See the original post:
Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a Rapid SARS-CoV-2 3CL Protease Detection Assay

Read the rest here:
Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules EN1001, EN2001 and EN3001

Read the original here:
A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in...

Read more from the original source:
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference

Original post:
Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Link:
Tauriga Sciences Inc. Updates Shareholders on Progress Pursuant to the Collaboration Agreement with Aegea Biotechnologies Inc. for New COVID-19...

Read this article:
NTG Nordic Transport Group publishes interim report for Q3 2020 and announces share-based incentive program and share buy-back program

More here:
Diabetes Freedom Reviews: Does George Reilly Program Book Really Work?

Follow this link:
European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

Read the original here:
Aquestive Therapeutics Completes FDA Type A Meeting on Libervant

Go here to read the rest:
Adamas to Present at Upcoming Piper Sandler Conference

Read more:
Chinook Therapeutics to Present at Upcoming Investor Conferences

See the rest here:
Immunicum AB and DCprime Combine Forces to Establish Leader in Cell-Based Cancer Immunotherapies

Continue reading here:
Notice of Extraordinary General Meeting in Immunicum AB (publ)

See the original post:
Immutep Completes a A$29.6 Million Placement to Accelerate and Broaden its Clinical Development

Link:
Immutep Announces Expansion of TACTI-002 Collaboration Trial

Original post:
Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001

See the original post:
Supernus to Participate in Annual Piper Sandler Healthcare Conference

See the rest here:
Sequana Medical Announces Positive Interim Data From North American Pivotal alfapump® Study (POSEIDON)

Follow this link:
LIDDS Interim report January – September 2020